I'm not quite following how the relationship between microbiome science and an infection of the microbiome is minimal. But more to your point, using the mg data from their "healthy" population along with the open-label…
The FDA disagrees with you (about the role of the microbiome -- I doubt they have an official opinion on biotech funding). C. Diff. is probably the biggest indication with multiple clinical trials going on to…
I'm not quite following how the relationship between microbiome science and an infection of the microbiome is minimal. But more to your point, using the mg data from their "healthy" population along with the open-label…
The FDA disagrees with you (about the role of the microbiome -- I doubt they have an official opinion on biotech funding). C. Diff. is probably the biggest indication with multiple clinical trials going on to…